✦ LIBER ✦

New drug for Parkinson's disease

Book ID: 111708564
Publisher: Elsevier Science
Year: 1949
Tongue: English
Weight: 139 KB
Volume: 248
Category: Article
ISSN: 0016-0032
DOI: 10.1016/0016-0032(49)90239-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Emerging analgesic drugs for Parkinson's

Emerging analgesic drugs for Parkinson's disease

✍ Perez-Lloret, Santiago; Rey, María Verónica; Dellapina, Estelle; Pellaprat, Jean 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 333 KB

New therapies for Parkinson's disease

✍ Ruth Djaldetti; Eldad Melamed 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 191 KB

Drug adherence in Parkinson's disease

✍ Norman A. Leopold; Marcia Polansky; Marcia R. Hurka 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

## Abstract :Physicians modify drug schedules in response to their patients' clinical responses. Failure to relieve patients' symptoms or the emergence of drug‐related side effects may reflect nonadherence to a prescribed drug schedule rather than incorrect therapeutic physician decisions. Using a

Neurodegenerative disease: New leads for

Neurodegenerative disease: New leads for Parkinson's disease

✍ Kingwell, Katie 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 220 KB

Neurodegenerative disease: New leads for

Neurodegenerative disease: New leads for Parkinson's disease

✍ Kingwell, Katie 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 327 KB

International guide to drugs for Parkins

International guide to drugs for Parkinson's disease

✍ Prof. Dr. W. H. Oertel; R. C. Dodel 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

## Abstract Pharmacotherapy of Parkinson's disease (PD) has become so effective that patients with PD can enjoy a nearly normal life, including travel for several years. The degree of international travel of patients with PD and in particular the recent increased coordination between health systems